Adenosine Deaminase Deficiency Associated Severe Combined Immunodeficiency
📧 Sign up to get email alerts when something new happens for Adenosine Deaminase Deficiency Associated Severe Combined Immunodeficiency.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-12-05FDA Approved: REVCOVI — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for REVCOVI (elapegademase-lvlr) by Chiesi USA, Inc., resulting in changes to its labeling.